BIOLIFE SOLUTIONS INC
About BIOLIFE SOLUTIONS INC
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2014
- $6.2M
- Net income
- -$4.6M
- Total assets
- $405.9M
- Market cap
- $1.3B
- Gross margin
- 64.6%
- Operating margin
- -17.3%
- Net margin
- -4.8%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $96.2M
- Cost of revenue
- $34.1M
- Gross profit
- $62.1M
- Operating expenses
- $78.7M
- Operating income
- -$16.6M
- Income tax
- $49.0K
- Net income
- -$4.6M
- EPS (basic)
- $-0.09
- EPS (diluted)
- $-0.10
Balance sheet
- Total assets
- $405.9M
- Current assets
- $136.6M
- Total liabilities
- $34.0M
- Current liabilities
- $23.0M
- Shareholders’ equity
- $371.9M
Cash flow
- Operating cash flow
- $20.1M
- Investing cash flow
- -$71.5M
- Financing cash flow
- -$10.9M
- Net cash flow
- -$62.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $1.3B
- EPS (diluted)
- $-0.1
- Shares outstanding
- 49.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 22, 1989
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $4.6M in FY2014.
- Revenue grew 100% from FY2020 to FY2025.
- Gross margin of 64.6%, net margin -4.8%.
- Trading 9% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review BIOLIFE SOLUTIONS INC.
Write a review
News about BIOLIFE SOLUTIONS INC
News & sentiment via Polygon.io
